Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference19 articles.
1. U.S. Food and Drug Administration (FDA). Draft guidance for industry. Drug interaction studies—study design, data analysis, implications for dosing, and labeling recommendations. 2012. Available at: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm292362.pdf . Accessed 16 Sept 2012.
2. Giacomini KM, Huang SM, Tweedie DJ, et al. Membrane transporters in drug development. Nat Rev Drug Discov. 2010;9:215–36.
3. Yoshida K, Maeda K, Sugiyama Y. Transporter-mediated drug–drug interactions involving OATP substrates: predictions based on in vitro inhibition studies. Clin Pharmacol Ther. 2012;91:1053–64.
4. Hu ZY, Parker RB, Laizure SC. In vivo information-guided prediction approach for assessing the risks of drug–drug interactions associated with circulating inhibitory metabolites. Drug Metab Dispos. 2012;40:1487–94.
5. Shardlow CE, Generaux GT, MacLauchlin CC, et al. Utilizing drug–drug interaction prediction tools during drug development: enhanced decision making based on clinical risk. Drug Metab Dispos. 2011;39:2076–84.
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献